BioForce Nanosciences Holdings, Inc.
corporate_fare Company Profile
BioForce Nanosciences Holdings, Inc. (OTC:BFNH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 9 items for BFNH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 8/10. Across its 9 most recent items scored 7 or higher, the top rating is 10/10, with 7 rated 8 or above. Recent SEC coverage for BFNH spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- BioForce Q3 2026: Zero Revenue, $31,696 Cash, Going Concern and Material Weakness Reiterated
- BioForce Pays for $2.48M in Services with 4.5M Restricted Shares
- BioForce Discloses Ryder Scott Prospective Resources Report for Nevada Leases
- BioForce Nanosciences Flags Zero Revenue, Going Concern, and Control Weaknesses in Q2 2026
- BLM Approves BioForce Nanosciences' 20,000-Acre Nevada Oil & Gas Lease Transfer
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 5,430 shares in BFNH as of the October 30, 2026 settlement, a 99.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 59.6% of BFNH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BFNH, detected from its recent SEC filings · based on capital-structure filings through 2026-09-04.
4.5M Restricted Shares Issued · Services Valued at $2.48M
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →